Using Stem Cell-Derived Neurons in High Content Screening Assays for Drug Toxicity on SelectScience

Drug Discovery
/ Webinars

Using Stem Cell-Derived Neurons in High Content Screening Assays for Drug Toxicity
27 Jun 2012

During this webinar, we will demonstrate the utility of several toxicity screening assays using iCell Neurons with the Molecular Devices ImageXpress® Micro High Content Imaging System. Experiments were run in 96 or 384 well plates to evaluate cell death, apoptosis, mitochondrial membrane damage, and impact on development of neuronal outgrowths over time.

Molecular Devices®

Watch Webinar

Show per page

1 of 1 Page 1 Next

Overcoming the Challenges of Sample Preparation and LC/MS/MS Method Development for Clinical Applications	21 May 2013	Read
Improve Efficiency of Variant Screening for Biological Drugs	2 May 2013	Read
Automated TruSeq RNA Sample Preparation from FFPE tissue	21 Dec 2012	Read
Live cell imaging to investigate the regulation of cell division timing	14 Nov 2012	Read
iCell® Neurons: Bringing Relevant Neuronal Biology to the Bench	30 Oct 2012	Read
Do you know what's in your laboratory water?	1 Oct 2012	Read
New Developments in Accelerating the High Content Screening Workflow	9 Aug 2012	Read
Using high-throughput RNAi screening to identify cellular factors involved in host-pathogen interactions	10 Jul 2012	Read
Using Stem Cell-Derived Neurons in High Content Screening Assays for Drug Toxicity	27 Jun 2012	Read
Automating High-Throughput Sample Prep for the Analysis of Complex Diseases Using Next Generation Sequencing	24 Apr 2012	Read